Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. D. Barber
The Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) in Early Breast Cancer: Results of a Pre-Operative Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Rationale for a Phase I Trial of Erlotinib and the Mammalian Target of Rapamycin Inhibitor Everolimus (RAD001) for Patients With Relapsed Non Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin
Clinical Cancer Research
Cancer Research
Oncology
Combination Therapy for Treating Breast Cancer Using Antiestrogen, ERA-923, and the Mammalian Target of Rapamycin Inhibitor, Temsirolimus
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells
Cancer Research
Cancer Research
Oncology
New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists
Breast Cancer Research
Cancer Research
Oncology
Ku-0063794 Is a Specific Inhibitor of the Mammalian Target of Rapamycin (mTOR)
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Correction: An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1.
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Inhibition of the Mammalian Target of Rapamycin (mTOR) in Advanced Pancreatic Cancer: Results of Two Phase II Studies
BMC Cancer
Cancer Research
Oncology
Genetics
Downregulation of Notch Pathway by a -Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model
Cancer Research
Cancer Research
Oncology
